Jay Moorin is 10% at CADENCE PHARMACEUTICALS INC (CADX). They have made 18 open-market trades across 8 companies since 2006, most recently 2017-11-28.
CIK 0001033508
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
10 open-market purchases totalling $10.8M since 2006, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| URGN | 1,419,838 | $49.0M |
| ACHN | 2,663,854 | $18.0M |
| IMDZ | 2,138,858 | $12.5M |
| EGRX | 172,381 | $369K |
| NVD | 6,267,570 | — |
| NVDL | 34,650,709 | — |
| AVNR | 7,125,754 | — |
| NOVC | 1,855,275 | — |
| CADX | 3,018,369 |
Shares reported on the most recent Form 4, priced at the 2017-11-29 close. 5 holdings could not be priced and are excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 80% |
| Avg Move | -33.4% | -2.0% | +4.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| URGN | SELL | 2017-11-27 | 2017-11-29 | $40.60 | $17.0M | -6.0% | -7.3% | +24.2% |
| IMDZ | SELL | 2015-05-12 | 2015-05-13 | $21.60 | $3.8M | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2015-04-17 | 2015-04-21 | $26.51 | $1.2M | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2015-03-16 | 2015-03-18 | $26.09 | $1.3M | -45.2% | -0.3% | -0.3% |
| EGRX | BUY | 2014-02-18 | 2014-02-20 | $15.00 | $5.0M | -8.4% | -0.4% | -0.4% |
| ACHN | SELL | 2009-12-16 | 2009-12-18 | $3.49 | $2.0M | -25.7% | -1.9% | -1.9% |
| AVNR | SELL | 2009-10-09 | 2009-10-13 | $2.31 | $4.1M | N/A | N/A | N/A |
| AVNR | BUY | 2008-10-22 | 2008-10-24 | $0.48 | $5K | N/A | N/A | N/A |
| AVNR | BUY | 2008-10-10 | 2008-10-15 | $0.47 | $52K | N/A | N/A | N/A |
| AVNR | BUY | 2008-10-07 | 2008-10-10 | $0.49 | $87K | N/A | N/A | N/A |
| AVNR | BUY | 2008-09-15 | 2008-09-17 | $0.82 | $552K | N/A | N/A | N/A |
| AVNR | BUY | 2008-08-14 | 2008-08-18 | $0.95 | $114K | N/A | N/A | N/A |
| AVNR | BUY | 2008-08-06 | 2008-08-08 | $0.98 | $90K | N/A | N/A | N/A |
| CADX | SELL | 2007-08-30 | 2007-08-31 | $14.10 | $61K | N/A | N/A | N/A |
| CADX | SELL | 2007-08-28 | 2007-08-30 | $14.04 | $159K | N/A | N/A | N/A |
| NVD | BUY | 2007-01-05 | 2007-01-26 | $1.45 | $1.4M | N/A | N/A | N/A |
| NOVC | BUY | 2006-05-15 | 2006-05-17 | $6.50 | $2.5M | N/A | N/A | N/A |
| NVD | BUY | 2006-04-12 | 2006-04-14 | $1.45 | $1.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| — |
| Total | $79.9M |